Disease · HP_0002153
Comparisons in its trials19
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 19 of 19
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Acute Phase: ZS vs Extended Dosing Phase: ZS: deaths from any cause | 0 of 751 | 8 of 746 | 1,497 | NCT02163499 | Trial comparisons |
| Acute Phase: ZS vs Extended Dosing Phase: ZS: serious adverse events | 1 of 751 | 161 of 746 | 1,497 | NCT02163499 | Trial comparisons |
| Patiromer vs Placebo: deaths from any cause | 24 of 439 | 18 of 439 | 878 | NCT03888066 | Trial comparisons |
| Patiromer vs Placebo: serious adverse events | 54 of 439 | 58 of 439 | 878 | NCT03888066 | Trial comparisons |
| Correction Phase vs Maintenance Phase: deaths from any cause | 0 of 150 | 2 of 150 | 300 | NCT03172702 | Trial comparisons |
| Correction Phase vs Maintenance Phase: serious adverse events | 1 of 150 | 27 of 150 | 300 | NCT03172702 | Trial comparisons |
| Sodium Zirconium Cyclosilicate (SZC) vs Placebo: deaths from any cause | 1 of 96 | 0 of 99 | 195 | NCT03303521 | Trial comparisons |
| Sodium Zirconium Cyclosilicate (SZC) vs Placebo: serious adverse events | 7 of 96 | 8 of 99 | 195 | NCT03303521 | Trial comparisons |
| Group 1 - Dosing Without Food vs Group 2 - Dosing With Food: deaths from any cause | 1 of 57 | 0 of 56 | 113 | NCT02694744 | Trial comparisons |
| Group 1 - Dosing Without Food vs Group 2 - Dosing With Food: serious adverse events | 4 of 57 | 1 of 56 | 113 | NCT02694744 | Trial comparisons |
| Patiromer Oral Powder Product vs Usual Care Arm: Number of Participants Who Completed All Study Visits | 16 of 17 | 15 of 16 | 33 | NCT03781089 | Trial comparisons |
| Patiromer Oral Powder Product vs Usual Care Arm: deaths from any cause | 0 of 17 | 0 of 16 | 33 | NCT03781089 | Trial comparisons |
| Patiromer Oral Powder Product vs Usual Care Arm: serious adverse events | 2 of 17 | 2 of 16 | 33 | NCT03781089 | Trial comparisons |
| Sodium Polystyrene Sulfonate vs Silicified Microcrystalline Cellulose: serious adverse events | 2 of 15 | 0 of 17 | 32 | NCT01866709 | Trial comparisons |
| Patiromer Oral Powder Product vs Usual Care Arm: Number of Participants With More Than 1000 Premature Ventricular Contractions (PVCs) in 24 Hours | 2 of 16 | 4 of 15 | 31 | NCT03781089 | Trial comparisons |
| Patiromer vs Standard of Care: deaths from any cause | 0 of 15 | 0 of 15 | 30 | NCT02933450 | Trial comparisons |
| Patiromer vs Standard of Care: serious adverse events | 0 of 15 | 0 of 15 | 30 | NCT02933450 | Trial comparisons |
| Cohort 1 vs Cohort 2: deaths from any cause | 0 of 14 | 0 of 9 | 23 | NCT03087058 | Trial comparisons |
| Cohort 1 vs Cohort 2: serious adverse events | 0 of 14 | 0 of 9 | 23 | NCT03087058 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0002153/comparisons